Paula M. Vertino

12.4k citations
105 papers · 9.5k indexed · 2 hit papers · h-index 49

Paula M. Vertino

103 papers receiving 9.3k citations

Hit Papers

CRISPR/Cas9 systems have off-target...482199720262006201650010001.5k

Peers

Paula M. Vertino
Comparison fields: 5 of 141
  • Molecular Biology 7.7k
  • Cancer Research 1.3k
  • Oncology 1.4k
  • Genetics 1.4k
  • Aging 85
Replace Xiwei Wu with:
Xiwei Wu United States
Grigory L. Dianov United Kingdom
Ji Luo United States
Thales Papagiannakopoulos United States
Melanie Boerries Germany
Ceshi Chen China
Wilbert Zwart Netherlands
Arjun Bhutkar United States
Scott Powers United States
Paula M. Vertino relative to Xiwei Wu United States Xiwei Wu's profile →
Citations per field
00.5×1.6×
Xiwei Wu · 1×
Citations per year

Countries citing papers authored by Paula M. Vertino

Since Specialization
Citations

This map shows the geographic impact of Paula M. Vertino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula M. Vertino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula M. Vertino more than expected).

Fields of papers citing papers by Paula M. Vertino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula M. Vertino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula M. Vertino. The network helps show where Paula M. Vertino may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paula M. Vertino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paula M. Vertino Line = papers co-authored together Paula M. Vertino links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20231
2 202110
3 20216
4 201927
5 201828
6 201825
7 20171
8 2016183
9 201526
10 201432
11 201162
12 201027
13 201089
14 2010418
15 200851
16 200880
17 200881
18 200862
19 200488
20 200120

About Paula M. Vertino

Paula M. Vertino is a scholar working on Molecular Biology, Cancer Research and Hematology, having authored 105 papers that have together received 9.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (51 papers), RNA modifications and cancer (28 papers), Cancer-related gene regulation (23 papers), Genomics and Chromatin Dynamics (12 papers), Childhood Cancer Survivors' Quality of Life (9 papers), Multiple Myeloma Research and Treatments (8 papers), Cancer survivorship and care (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Molecular Biology (7.7k citations), Cancer Research (1.3k citations) and Oncology (1.4k citations). Paula M. Vertino has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Jean‐Pierre J. Issa, Jeremy R. Graff, James G. Herman, Stephen B. Baylin, Xiaodong Cheng, Michael T. McCabe, Dipali Sharma, Hideharu Hashimoto, Beth B. McConnell and Neeraj K. Saxena. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026